{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T23:02:19Z","timestamp":1771023739759,"version":"3.50.1"},"reference-count":13,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,2,24]],"date-time":"2022-02-24T00:00:00Z","timestamp":1645660800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Mucormycosis is a rare and invasive fungal infection with high mortality. Cases of invasive pulmonary mucormycosis that involve allergic reactions such as allergic bronchopulmonary mycosis are rarely reported. Herein, we describe a case of invasive pulmonary mucormycosis overlapping with allergic diseases in a patient who presented with eosinophilia and high total plasma immunoglobulin E (IgE). The patient was successfully treated with systemic corticosteroids (initial dose of prednisolone approximately 0.5 mg\/kg per day, total duration less than 3 months) combined with posaconazole antifungal therapy. The treatment resulted in recovery of peripheral-blood eosinophil count and total plasma IgE, and significant reduction in lung lesions. A subsequent lobectomy was performed. The findings in this case indicate that systemic corticosteroid therapy may contribute to the treatment of pulmonary mucormycosis combined with allergic factors.<\/jats:p>","DOI":"10.3389\/fmed.2022.831213","type":"journal-article","created":{"date-parts":[[2022,2,24]],"date-time":"2022-02-24T06:35:11Z","timestamp":1645684511000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Allergic Bronchopulmonary Mycosis Caused by Mucor Overlapping With Invasive Pulmonary Mucormycosis: A Case Report"],"prefix":"10.3389","volume":"9","author":[{"given":"Ruhui","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ge","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasheng","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisha","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yake","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiqi","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianying","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,2,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"856","DOI":"10.3389\/fimmu.2020.00856","article-title":"Editorial: host and pathogen determinants of allergic and invasive fungal diseases","volume":"11","author":"Obar","year":"2020","journal-title":"Front Immunol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1111\/myc.12958","article-title":"Mucormycosis in South America: a review of 143 reported cases","volume":"62","author":"Nucci","year":"2019","journal-title":"Mycoses."},{"key":"B3","first-page":"758","article-title":"Pulmonary mucormycosis caused by Cunninghamella bertholletiae in a non-immunocompromised woman","volume":"39","author":"Sato","year":"2001","journal-title":"Nihon Kokyuki Gakkai Zasshi."},{"key":"B4","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12890-017-0419-1","article-title":"Invasive pulmonary mucormycosis: rare presentation with pulmonary eosinophilia","volume":"17","author":"Hirano","year":"2017","journal-title":"BMC Pulm Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"75","DOI":"10.23822\/EurAnnACI.1764-1489.87","article-title":"Allergic bronchopulmonary mycosis due to fungi other than aspergillus","volume":"51","author":"Deepak","year":"2019","journal-title":"Eur Ann Allergy Clin Immunol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1111\/cea.12141","article-title":"Allergic bronchopulmonary aspergillosis : review of literature and proposal of new diagnostic and classification criteria","volume":"43","author":"Agarwal","year":"2013","journal-title":"Clin Exp Allergy"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1016\/j.jaci.2020.08.029","article-title":"New clinical diagnostic criteria for allergic bronchopulmonary aspergillosis\/mycosis and its validation","volume":"147","author":"Asano","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/j.jaci.2020.11.029","article-title":"Is the \u201cprobable\u201d category required in the diagnosis of ABPA?","volume":"147","author":"Muthu","year":"2021","journal-title":"J Allergy Clin Immunol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3109\/1040841X.2012.754401","article-title":"Allergic bronchopulmonary mycosis due to fungi other than Aspergillus: a global overview","volume":"40","author":"Chowdhary","year":"2014","journal-title":"Crit Rev Microbiol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1016\/j.jaip.2021.01.044","article-title":"Refractory thoracic conidiobolomycosis treated with mepolizumab immunotherapy","volume":"9","author":"Fracp","year":"2021","journal-title":"J Allergy Clin Immunol Pract."},{"key":"B11","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1183\/13993003.01475-2015","article-title":"A randomised trial of glucocorticoids in acute-stage allergic bronchopulmonary aspergillosis complicating asthma","volume":"47","author":"Agarwal","year":"2016","journal-title":"Eur Respir J."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/AAC.02655-17","article-title":"Antifungal prophylaxis with posaconazole delayed-release tablet and oral suspension in a real-life setting: plasma levels, efficacy, and tolerability","volume":"62","author":"Lenczuk","year":"2018","journal-title":"Antimicrob Agents Chemother."},{"key":"B13","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s12281-016-0255-4","article-title":"Therapeutic drug monitoring of posaconazole: an update","volume":"10","author":"Dekkers","year":"2016","journal-title":"Curr Fungal Infect Rep."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.831213\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,24]],"date-time":"2022-02-24T06:35:14Z","timestamp":1645684514000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.831213\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,24]]},"references-count":13,"alternative-id":["10.3389\/fmed.2022.831213"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.831213","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,24]]},"article-number":"831213"}}